Industry

Zocdoc Founder Cyrus Massoumi Launches Nationwide Telehealth Platform That Also Provides No-Cost Care to Low-Income Americans With “Visitless Prescriptions” From Dr. B, Patients Can Conveniently Access Critical Medications From Home NEW YORK–(BUSINESS WIRE)–Dr. B launches the first telehealth company that makes healthcare services available regardless of a patient’s ability to pay. The company is initially … [Read more…]

Six-member advisory board offers diverse look at M&A industry WINTER PARK, Fla.–(BUSINESS WIRE)–Align Business Advisory Services, a top-rated mergers & acquisitions (M&A) advisory firm for lower-middle market businesses, announces its first advisory board to help support the team’s growth in current and new markets. The six members of the advisory board represent a diverse group … [Read more…]

Taking learnings from COVID-19, new GetWell Loop care plan aims to help manage and slow spread of monkeypox BETHESDA, Md.–(BUSINESS WIRE)–Get Well, a leading global digital health company, today announced it has released a new monkeypox digital care management plan. This is the first digital care plan for monkeypox to be released in the industry. … [Read more…]

Company Appoints Accomplished Biotech Leaders Sanuj Ravindran, M.D., as Chief Executive Officer and Jake Bauer as Independent Director and Chair NEW HAVEN, Conn. & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Simcha Therapeutics (“Simcha”), a clinical-stage immunobiology company pioneering first-in-class cytokine treatments in cancer, today announced the appointment of Sanuj Ravindran, M.D., as chief executive officer and director, … [Read more…]

BOSTON–(BUSINESS WIRE)–Abacus Insights, a healthcare technology leader with the only cloud-based data transformation platform built specifically for health plans, is rolling out a suite of solutions that revolutionizes how payers can leverage data for faster and better decision making. Abacus Insights has introduced solutions that sort, bundle and continually update validated, transformed data to serve … [Read more…]

In partnership with the University of Melbourne, the restoration of this unique keystone species, which was hunted aggressively to extinction, holds promise of ecosystem restoration for Tasmania DALLAS–(BUSINESS WIRE)–Colossal Biosciences, a breakthrough genetic engineering and de-extinction company, announces it has started the de-extinction of the thylacine, a beloved Australian marsupial that was eradicated by human … [Read more…]

FREMONT, Calif.–(BUSINESS WIRE)–Moximed, a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced $40 million in Series C equity and debt financing. The round was led by Advent Life Sciences and also included returning investors New Enterprise Associates (NEA), Future Fund, Vertex Healthcare, Gilde … [Read more…]

Stressed farmed animals pose a significant public health risk, doctors say WASHINGTON–(BUSINESS WIRE)–The Physicians Committee for Responsible Medicine, a national public health nonprofit of more than 17,000 doctor members, filed an amicus brief with the U.S. Supreme Court on Monday, Aug. 15, in support of California’s Proposition 12, a law establishing confinement standards for pigs … [Read more…]

First PARP inhibitor to demonstrate clinical benefit in radiographic progression-free survival in combination with a new hormonal agent with or without homologous recombination repair gene mutations RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that a supplemental New Drug Application (sNDA) for LYNPARZA in … [Read more…]

First PARP inhibitor to demonstrate clinical benefit in combination with a new hormonal agent irrespective of homologous recombination repair (HRR) gene mutations WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca’s supplemental New Drug Application (sNDA) for LYNPARZA® (olaparib) in combination with abiraterone and prednisone or prednisolone has been accepted and granted Priority Review in the US for the treatment of … [Read more…]